DNA recognition by two mitoxantrone analogues: Influence of the hydroxyl groups

FEBS Letters

Volumn 379, Issue 3, 1996, Pages 269-272

  Bailly, Christian ^a   Routier, Sylvain ^b   Bernier, Jean Luc ^b   Waring, Michael J ^c  

^a Institut de Recherche sur le Cancer de Lille   (France)

^b CNRS   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Anticancer drug; DNA recognition; Footprinting; Mitoxantrone

Indexed keywords

AMETANTRONE; ANTHRAQUINONE DERIVATIVE; MITOXANTRONE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA FOOTPRINTING; DRUG SYNTHESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0030071480     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(95)01528-0     Document Type: Article

References (30)

1. van de Graaf, W.T.A. and de Vries, E.G.E. (1990) Anti-Cancer Drugs 1, 109-125.
2. Faulds, D., Balfour, J.A., Chrisp, P. and Langtry, H.D. (1991) Drugs 41, 400-449.
3. Kapuscinski, J. and Darzynkiewicz, Z. (1986) Proc. Natl. Acad. Sci. USA 83, 6302-6306.
4. Fox, M.E. and Smith, R.J. (1990) Cancer Res. 50, 5813-5818.
5. Fisher, G.R., Brown, J.R. and Patterson, L.H. (1990) Free. Rad. Res. Commun. 11, 117-125.
6. Fisher, G.R., Gutierrez, P.L., Oldcorne, M.A. and Patterson, L.H. (1992) Biochem. Pharmacol. 43, 575-585.
7. Capranico, G., De Isabella, P., Tinelli, S., Bigioni, M. and Zunino, F. (1994) Biochemistry 32, 3038-3046.
8. Lown, J. W., Reszka, K., Kolodziejczyk, P. and Wilson, W. D. (1987) in: Molecular Mechanisms of Carcinogenic and Antitumor Activity (Chagas, C. and Pullman, B., Eds.) pp. 243-274, Adenine Press, New York.
9. Reszka, K., Kolodziejczyk, P., Hartley, J.A., Wilson, W.D. and Lown, J.W. (1988) in: Bioactive Molecules (Lown, J.W., Ed.) Vol. 6, Elsevier, Amsterdam, pp. 401-445.
10. Kapuscinski, J., Darzynkiewicz, Z., Traganos, F. and Melamed, M. R. (1981) Biochem. Pharmacol. 30, 231-240.
11. Lown, J.W., Morgan, A.R., Yen. S.-F., Wang, Y.H. and Wilson, W.D. (1985) Biochemistry 24, 4028-4035.
12. Gandecha, B.M., Brown, J.R. and Crampton, M.R. (1985) Biochem. Pharmacol. 34, 337-346.
13. Krishnamoorthy, C.R., Yen, S.-F., Smith, J.C., Lown, J.W. and Wilson, W.D. (1986) Biochemistry 25, 5933-5940.
14. Kotovych, G., Lown, J.W. and Tong, J.P.K. (1986) J. Biomol. Struct. Dyn. 4, 111-125.
15. Denny, W.A. and Wakelin, L.P.G. (1990) Anti-Cancer Drug Des. 5, 189-20.
16. Fox, K.R., Waring, M.J., Brown, J.R. and Neidle, S. (1986) FEBS Lett. 202, 289-294.
17. Chen, K.-X., Gresh, N. and Pullman, B. (1986) Nucleic Acids Res. 14, 3779-3812.
18. Panousis, C. and Phillips, D.R. (1994) Nucleic Acids Res. 22, 1342-1345.
19. Collier, D.A. and Neidle, S. (1988) J. Med. Chem. 31, 847-857.
20. Tanious, F.A., Jenkins, T.C.., Neidle, S. and Wilson, W.D. (1992) Biochemistry 31, 11632-11640.
21. Palumbo, M., Palù, G., Gia, O., Ferrazzi, E., Gastaldi, S., Antonello, C. and Meloni, G.A. (1987) Anti-Cancer Drug Des. 1, 337-346.
22. Greenhalgh, C.W. and Hughes, N. (1968) J. Chem. Soc. 1284.
23. Morier-Teissier, E., Boitte, N., Helbecque, N., Bernier, J.L., Pommery, N., Duvalet, J.L., Fournier, C., Hecquet, B., Catteau, J.P. and Hénichart, J.P. (1993) J. Med. Chem. 36, 2084-2090.
24. Waring, M.J. and Henley, S.M. (1975) Nucleic Acids Res. 2, 567-586.
25. Bailly, C., Braña, M. and Waring, M.J. (1996) Biochemistry, submitted.
26. Bailly, C. and Waring, M.J. (1993) Biochemistry 32, 5985-5993.
27. Bailly, C. and Waring, M.J. (1995) Nucleic Acids Res. 23, 885-892.
28. Low, C.M.L., Drew, H.R. and Waring, M.J. (1984) Nucleic Acids Res. 12, 4865-4877.
29. Islam, S.A., Neidle, S., Gandecha, B.M., Partridge, M., Patterson, L.H. and Brown, J.R. (1985) J. Med. Chem. 28, 857-864.
30. Waring, M.J. and C. Bailly (1994) J. Mol. Recognition 7, 109-122.